Aditya Jayawant Athare

Aditya Jayawant Athare

Active Director Director DIN 08066017
DIN 08066017 First appointment May 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Aditya Jayawant Athare

Data last updated:

Aditya Jayawant Athare is a Director at Athare Patil Pharma Private Limited (since 2018). The company operates in Business Services.

DIN 08066017
Primary Designation Director
Industry Business Services
First Appointment 24 May 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Athare Patil Pharma Private Limited U74999PN2018PTC176817
Director24 May 20182018Active

Board colleagues of Aditya Jayawant Athare

NameDINCompanyDesignation
Asif Amin Inamdar08065982Athare Patil Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Athare Patil Pharma Private Limited
Premium access

Shareholding and investment profile for Aditya Jayawant Athare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aditya Jayawant Athare

Aditya Jayawant Athare currently holds 1 directorship: Athare Patil Pharma Private Limited (Director, since 24 May 2018).

Aditya Jayawant Athare was first appointed on 24 May 2018 as Director at Athare Patil Pharma Private Limited.

The current boards of Aditya Jayawant Athare's companies include Asif Amin Inamdar (Athare Patil Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available